Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Pfizer
Hoffmann-La Roche
EMD Serono
Boehringer Ingelheim
Takeda
Bolt Biotherapeutics, Inc.
Shasqi, Inc.
Tempus AI
Actym Therapeutics, Inc.
EMD Serono
Bolt Biotherapeutics, Inc.
Ascendis Pharma A/S
Regeneron Pharmaceuticals
Elevation Oncology
Alentis Therapeutics AG
Aminex Therapeutics, Inc.
Atara Biotherapeutics
Rakuten Medical, Inc.
Inhibrx Biosciences, Inc
Novartis
GlaxoSmithKline
Merck Sharp & Dohme LLC
GlaxoSmithKline
Pfizer
Ikena Oncology
SQZ Biotechnologies
CytomX Therapeutics
MacroGenics
Merck Sharp & Dohme LLC
Fate Therapeutics
SecuraBio
Fate Therapeutics
Hoffmann-La Roche
Genmab
SynCore Biotechnology Co., Ltd.
Monopar Therapeutics
Seagen Inc.
Advaxis, Inc.
Celgene
Nektar Therapeutics
Aethlon Medical Inc.
Rubius Therapeutics
Repertoire Immune Medicines
Presage Biosciences
Inovio Pharmaceuticals
Inovio Pharmaceuticals
PCI Biotech AS
Chinook Therapeutics, Inc.
Dynavax Technologies Corporation